BOOK
Adolescent Sexuality, An Issue of Pediatric Clinics of North America, E-Book
(2017)
Additional Information
Book Details
Abstract
Dr. Felice has put together clinical reviews articles that cover a broad scope of clinical issues that are common among sexually active adolescent patients. Some issues addressed include: HPV Vaccine Update; Treating Dysmenorrhea/Menorrhagia; New STD Guidelines; Emergency Contraception; Talking to Parents about Teen Sexuality; and Long-acting Reversible Contraception. Most pediatricians feel poorly equipped to address these problems. They are also complicated issues that give the average pediatric clinician pause and often take more time than usually scheduled in a busy practice. By providing practical updated information on these clinical problems, pediatric practitioners can become more comfortable in dealing with these topics. Although many clinicians are not involved with adolescents in the juvenile justice system, Dr. Felice included an article on this so that pediatricians can be more educated and sensitive to the needs of these young people. An article on human trafficking of teens in included with the hope bringing awareness of this issue. Articles in this issue were selected specifically because they directly affect primary pediatric care. For example, an article is included on how to help young people avoid being victims of partner violence rather than an article on sexual abuse and rape because adolescents would be treated in the emergency room and not the pediatrician’s office.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Adolescent Sexuality | i | ||
| Copyright\r | ii | ||
| CME Accreditation Page | iii | ||
| PROGRAM OBJECTIVE | iii | ||
| TARGET AUDIENCE | iii | ||
| LEARNING OBJECTIVES | iii | ||
| ACCREDITATION | iii | ||
| DISCLOSURE OF CONFLICTS OF INTEREST | iii | ||
| UNAPPROVED/OFF-LABEL USE DISCLOSURE | iii | ||
| TO ENROLL | iv | ||
| METHOD OF PARTICIPATION | iv | ||
| CME INQUIRIES/SPECIAL NEEDS | iv | ||
| Contributors | v | ||
| CONSULTING EDITOR | v | ||
| EDITOR | v | ||
| AUTHORS | v | ||
| Contents | ix | ||
| Foreword: Adolescents Too Are Not Just “Little Adults” | ix | ||
| Preface: A Primer for Primary Care Clinicians Caring for Sexually Active Adolescents | ix | ||
| Interviewing Adolescents About Sexual Matters | ix | ||
| Talking to Parents About Adolescent Sexuality | ix | ||
| Human Papillomavirus Vaccine Update | ix | ||
| The Treatment of Dysmenorrhea | x | ||
| Choosing the Right Oral Contraceptive Pill for Teens | x | ||
| Long-Acting Reversible Contraception: An Essential Guide for Pediatric Primary Care Providers | x | ||
| Sometimes You Do Get a Second Chance: Emergency Contraception for Adolescents | x | ||
| Adolescent Pregnancy | xi | ||
| Adolescent Sexuality: Updates to the Sexually Transmitted Infection Guidelines | xi | ||
| Sex Trafficking of Minors | xi | ||
| Prevention of and Interventions for Dating and Sexual Violence in Adolescence | xi | ||
| Sexuality and Disability in Adolescents | xii | ||
| Treating Youths in the Juvenile Justice System | xii | ||
| PEDIATRIC CLINICS OF\rNORTH AMERICA\r | xiii | ||
| FORTHCOMING ISSUES | xiii | ||
| June 2017 | xiii | ||
| August 2017 | xiii | ||
| December 2017 | xiii | ||
| RECENT ISSUES | xiii | ||
| February 2017 | xiii | ||
| December 2016 | xiii | ||
| October 2016 | xiii | ||
| Foreword: Adolescents Too Are Not Just “Little Adults”\r | xv | ||
| Preface:\rA Primer for Primary Care Clinicians Caring for Sexually Active Adolescents | xvii | ||
| Interviewing Adolescents About Sexual Matters | 291 | ||
| Key points | 291 | ||
| INTRODUCTION | 291 | ||
| SUMMARY | 295 | ||
| OBTAINING THE SEXUAL HISTORY | 295 | ||
| Assumptions | 298 | ||
| Judgment | 298 | ||
| WHAT NEXT? WHAT TO DO WITH THE SEXUAL HISTORY | 301 | ||
| SUPPLEMENTARY DATA | 303 | ||
| REFERENCES | 303 | ||
| Talking to Parents About Adolescent Sexuality | 305 | ||
| Key points | 305 | ||
| INTRODUCTION | 305 | ||
| Parents Talking with Adolescents About Sexuality: Best Practices | 307 | ||
| Talking about sexuality, in general | 307 | ||
| Topics covered when talking about sexuality | 307 | ||
| Anatomy/physiology | 307 | ||
| Puberty | 309 | ||
| Masturbation | 310 | ||
| Oral sex and anal sex | 310 | ||
| Abstinence | 310 | ||
| Harm reduction | 314 | ||
| Prevention | 315 | ||
| Vaccination | 315 | ||
| Reproductive health care | 315 | ||
| Connectedness with adults who care | 316 | ||
| Engagement with activities and interests | 316 | ||
| Romantic relationships | 316 | ||
| Sexual orientation | 316 | ||
| Contraception | 317 | ||
| Media/pornography | 317 | ||
| Sexual abuse/exploitation | 318 | ||
| Concrete Tips for Parents for Talking to Adolescents About Sexuality | 318 | ||
| SUMMARY | 318 | ||
| ACKNOWLEDGMENTS | 319 | ||
| REFERENCES | 319 | ||
| Human Papillomavirus Vaccine Update | 321 | ||
| Key points | 321 | ||
| INTRODUCTION | 321 | ||
| EPIDEMIOLOGY | 321 | ||
| PATHOPHYSIOLOGY AND NATURAL HISTORY | 322 | ||
| BURDEN OF DISEASE | 322 | ||
| AVAILABLE VACCINES FOR PREVENTION | 323 | ||
| IMMUNOGENICITY | 324 | ||
| EFFICACY AND SAFETY | 324 | ||
| VACCINE UPTAKE | 325 | ||
| SUMMARY | 327 | ||
| REFERENCES | 327 | ||
| The Treatment of Dysmenorrhea | 331 | ||
| Key points | 331 | ||
| INTRODUCTION | 331 | ||
| NORMAL MENSTRUAL PATTERNS IN ADOLESCENTS | 332 | ||
| EPIDEMIOLOGY | 333 | ||
| PATHOPHYSIOLOGY | 333 | ||
| PATIENT EVALUATION OVERVIEW | 333 | ||
| CLINICAL ASSESSMENT | 334 | ||
| History | 334 | ||
| Physical Examination | 334 | ||
| DIFFERENTIAL DIAGNOSIS | 334 | ||
| DIAGNOSTIC EVALUATION | 337 | ||
| TREATMENT | 337 | ||
| Pharmacologic Treatment Options | 337 | ||
| Primary dysmenorrhea | 337 | ||
| Nonsteroidal anti-inflammatory drugs | 337 | ||
| Hormonal Agents | 337 | ||
| Nonpharmacologic Treatment Options | 339 | ||
| Treatment of Secondary Dysmenorrhea | 339 | ||
| ADDITIONAL CONSIDERATIONS | 339 | ||
| REFERENCES | 340 | ||
| Choosing the Right Oral Contraceptive Pill for Teens | 343 | ||
| Key points | 343 | ||
| INTRODUCTION | 343 | ||
| TYPES OF ORAL CONTRACEPTIVE PILLS, MECHANISM OF ACTION, AND EFFICACY | 344 | ||
| ADDRESSING COMMON CULTURAL MYTHS ABOUT ORAL CONTRACEPTIVE PILLS | 344 | ||
| DECIDING BETWEEN PROGESTIN-ONLY PILLS AND COMBINED ORAL CONTRACEPTIVES | 345 | ||
| SMOKING AND COMBINED ORAL CONTRACEPTIVE USE | 346 | ||
| PRESCRIBING THE PROGESTIN-ONLY PILL | 346 | ||
| QUICK START METHOD | 347 | ||
| PRESCRIBING COMBINED ORAL CONTRACEPTIVES | 347 | ||
| NONCONTRACEPTIVE HEALTH BENEFITS OF COMBINED ORAL CONTRACEPTIVES | 348 | ||
| SIDE EFFECTS AND MEDICAL RISKS ASSOCIATED WITH COMBINED ORAL CONTRACEPTIVES | 348 | ||
| OBESITY AND COMBINED ORAL CONTRACEPTIVES | 349 | ||
| BREAST CANCER RISK AND COMBINED ORAL CONTRACEPTIVES | 349 | ||
| MEDICATION INTERACTIONS AND COMBINED ORAL CONTRACEPTIVES | 350 | ||
| DIFFERENCES AMONG COMBINED ORAL CONTRACEPTIVE FORMULATIONS | 350 | ||
| COMBINED ORAL CONTRACEPTIVES AND PROGESTINS | 351 | ||
| PROGESTINS AND CLOTTING RISK | 351 | ||
| PROGESTINS AND ANTIANDROGENIC EFFECTS | 351 | ||
| CHOOSING AN INITIAL COMBINED ORAL CONTRACEPTIVE FOR PATIENTS WITHOUT EXCESSIVE UTERINE BLEEDING, ACNE, HIRSUTISM, OR POLYCY ... | 352 | ||
| CHOOSING AN INITIAL COMBINED ORAL CONTRACEPTIVE FOR PATIENTS WITH MENORRHAGIA AND/OR EXCESSIVE UTERINE BLEEDING | 352 | ||
| CHOOSING AN INITIAL COMBINED ORAL CONTRACEPTIVE FOR PATIENTS WITH ACNE, HIRSUTISM, AND/OR POLYCYSTIC OVARY SYNDROME | 352 | ||
| MONOPHASIC VERSUS MULTIPHASIC COMBINED ORAL CONTRACEPTIVE FORMULATIONS | 353 | ||
| EXTENDED AND CONTINUOUS CYCLING | 353 | ||
| GENERAL FOLLOW-UP AND TROUBLESHOOTING SIDE EFFECTS | 355 | ||
| MANAGING MISSED PILLS | 355 | ||
| MANAGING PILL DOSING WITH VOMITING AND/OR DIARRHEA | 355 | ||
| PATIENTS WITH CHRONIC MEDICAL CONDITIONS AND COMBINED ORAL CONTRACEPTIVE USE | 355 | ||
| REFERRING TO ADOLESCENT MEDICINE OR GYNECOLOGY | 357 | ||
| SUMMARY | 357 | ||
| REFERENCES | 357 | ||
| Long-Acting Reversible Contraception | 359 | ||
| Key points | 359 | ||
| INTRODUCTION | 359 | ||
| DISCUSSION | 360 | ||
| Why Contraception for Adolescents? | 360 | ||
| Long-Acting Reversible Contraception Methods: How They Work | 361 | ||
| Why Long-Acting Reversible Contraception | 362 | ||
| Long-acting reversible contraception methods are the most effective contraceptive methods besides abstinence | 362 | ||
| Long-acting reversible contraception methods are safe | 363 | ||
| Long-acting reversible contraception methods are approved for most adolescents | 363 | ||
| Few drug interactions | 364 | ||
| Long-acting reversible contraception is affordable | 364 | ||
| Long-Acting Reversible Contraception Counseling in Primary Care | 364 | ||
| Dispelling common concerns | 364 | ||
| Confidentiality | 364 | ||
| Finding a provider of long-acting reversible contraception | 365 | ||
| After the long-acting reversible contraceptive is placed | 366 | ||
| Challenges | 366 | ||
| SUMMARY | 367 | ||
| Irregular Bleeding | 367 | ||
| Weight changes | 367 | ||
| Acne | 367 | ||
| Mood changes | 367 | ||
| Return to fertility | 367 | ||
| REFERENCES | 368 | ||
| Sometimes You Do Get a Second Chance | 371 | ||
| Key points | 371 | ||
| INTRODUCTION | 371 | ||
| EPIDEMIOLOGY | 372 | ||
| PREGNANCY RISK | 372 | ||
| THE HISTORICAL (AND POLITICAL) PERSPECTIVE | 372 | ||
| SPECIFIC FORMS OF EMERGENCY CONTRACEPTION | 375 | ||
| Indications for and Timing of Emergency Contraceptive Use | 375 | ||
| Copper intrauterine device | 375 | ||
| Ulipristal acetate | 375 | ||
| Mifepristone | 376 | ||
| Levonorgestrel | 377 | ||
| Yuzpe method (ethinyl estradiol + levonorgestrel) | 378 | ||
| COMMON MYTHS AND MISCONCEPTIONS ABOUT EMERGENCY CONTRACEPTION | 378 | ||
| ACKNOWLEDGMENTS | 379 | ||
| REFERENCES | 379 | ||
| Adolescent Pregnancy | 381 | ||
| Key points | 381 | ||
| OVERVIEW | 381 | ||
| EARLY DIAGNOSIS OF PREGNANCY | 382 | ||
| ADVERSE PERINATAL OUTCOMES | 383 | ||
| ACTIONS THAT CAN BE TAKEN IN THE PEDIATRIC OFFICE | 383 | ||
| REPEAT PREGNANCY | 385 | ||
| PREVENTION | 386 | ||
| SUMMARY | 386 | ||
| REFERENCES | 387 | ||
| Adolescent Sexuality | 389 | ||
| Key points | 389 | ||
| INTRODUCTION | 389 | ||
| CHLAMYDIA TRACHOMATIS INFECTIONS | 390 | ||
| Clinical Manifestations | 390 | ||
| Diagnosis and Screening | 390 | ||
| Treatment and Management | 391 | ||
| NEISSERIA GONORRHOEAE INFECTIONS | 391 | ||
| Clinical Manifestations | 391 | ||
| Diagnosis and Screening | 395 | ||
| Treatment and Management | 395 | ||
| Treatment Failures | 396 | ||
| TREPONEMA PALLIDUM INFECTIONS | 396 | ||
| Clinical Manifestations | 396 | ||
| Diagnosis and Screening | 397 | ||
| Treatment and Management | 397 | ||
| TRICHOMONAS VAGINALIS INFECTIONS | 397 | ||
| Sex Trafficking of Minors | 413 | ||
| Key points | 413 | ||
| DEFINITIONS | 413 | ||
| Sex Trafficking | 413 | ||
| Commercial Sexual Exploitation of Children | 413 | ||
| Domestic Minor Sex Trafficking | 414 | ||
| RISK | 414 | ||
| Epidemiology | 414 | ||
| Normative Adolescent Psychosocial Development | 414 | ||
| Risk Factors | 415 | ||
| RECRUITMENT | 415 | ||
| Grooming | 415 | ||
| Survivor-Exploiter Dynamics | 415 | ||
| Social Media | 415 | ||
| IDENTIFICATION | 416 | ||
| Barriers to Care | 416 | ||
| Provider Lack of Education/Awareness | 416 | ||
| Signs of Involvement in Domestic Minor Sex Trafficking | 416 | ||
| Screening Questions | 417 | ||
| MEDICAL RESPONSE | 417 | ||
| Acute Care | 417 | ||
| Follow-up Care | 418 | ||
| Sexually Transmitted Infection Testing and Treatment | 418 | ||
| Pregnancy Prevention | 418 | ||
| Safety Planning | 419 | ||
| MULTIDISCIPLINARY RESPONSE | 419 | ||
| FUTURE DIRECTIONS | 420 | ||
| REFERENCES | 420 | ||
| Prevention of and Interventions for Dating and Sexual Violence in Adolescence | 423 | ||
| Key points | 423 | ||
| BACKGROUND | 423 | ||
| Prevalence of Adolescent Relationship Abuse and Sexual Violence | 423 | ||
| Unique characteristics of adolescent relationship abuse | 424 | ||
| Reproductive coercion | 424 | ||
| Cyber dating abuse | 425 | ||
| Sexual and Reproductive Health Impacts | 425 | ||
| Preparing Your Practice | 426 | ||
| Assessment for Relationship Abuse and Sexual Violence | 426 | ||
| Primary prevention | 426 | ||
| Early intervention | 426 | ||
| Clinical red flags | 427 | ||
| Universal education, brief counseling, and warm referrals | 428 | ||
| Creating a safe environment for possible disclosure | 429 | ||
| Framing the conversation | 429 | ||
| Universalizing | 430 | ||
| Educational | 430 | ||
| Concrete | 430 | ||
| Collaborative model for care | 430 | ||
| Partnering with schools and youth serving agencies on prevention of adolescent relationship abuse and sexual violence | 431 | ||
| REFERENCES | 431 | ||
| Sexuality and Disability in Adolescents | 435 | ||
| Key points | 435 | ||
| INTRODUCTION | 435 | ||
| ADOLESCENTS WITH PHYSICAL DISABILITIES | 436 | ||
| Cerebral Palsy | 436 | ||
| Myelomeningocele | 437 | ||
| ADOLESCENTS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES | 437 | ||
| Autism Spectrum Disorders | 437 | ||
| Inappropriate Sexual Behaviors | 438 | ||
| Sexual Abuse and Exploitation | 438 | ||
| Caregivers’ Perspectives and Influence | 438 | ||
| SEXUALITY EDUCATION | 439 | ||
| THE ROLE OF THE MEDICAL PROVIDER | 440 | ||
| Puberty and Menstruation | 440 | ||
| Medical Interventions | 441 | ||
| Surgical Interventions | 442 | ||
| Supporting Healthy Sexuality | 443 | ||
| SUMMARY | 445 | ||
| REFERENCES | 445 | ||
| Treating Youths in the Juvenile Justice System | 451 | ||
| Key points | 451 | ||
| SEXUAL RISK PERSISTS DURING AND AFTER ANY JUSTICE SYSTEM CONTACT | 452 | ||
| GIRLS: A JUVENILE JUSTICE MINORITY POPULATION WITH UNIQUE RISK PROFILES | 453 | ||
| Child Abuse, Substance Use, and Mental Heath Issues Increase Girls′ Sexual Risks | 453 | ||
| Higher Female Rates of Sexually Transmitted Infections and Risky Sexual Behaviors and Partners | 454 | ||
| SPECIAL JUVENILE JUSTICE POPULATIONS: PREGNANT/PARENTING, GANGS, SEX-TRAFFICKING, LESBIAN, GAY, BISEXUAL, TRANSGENDER | 455 | ||
| Pregnancy and Parenting in Juvenile Justice Populations | 455 | ||
| Social Context and Influence: Impact of Gangs and Families | 456 | ||
| Minor Sex Trafficking Associated with Juvenile Justice Population | 457 | ||
| Nonheterosexual Youths Overrepresented in Juvenile Justice | 457 | ||
| Gender Bias: Historical Discriminatory Criminalization of Female | 458 | ||
| Sexuality | 458 | ||
| SUMMARY | 458 | ||
| REFERENCES | 459 | ||
| Index | 463 |